<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39320009</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022.</ArticleTitle><Pagination><StartPage>e70007</StartPage><MedlinePgn>e70007</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.70007</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In 2022, publicly funded influenza vaccine was made available to all residents of Queensland, Australia. This study compared influenza epidemiology in 2022 with previous years (2017-2021) and estimated influenza vaccine effectiveness (VE) during 2022.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study involved a descriptive analysis of influenza notifications and a case-control study to estimate VE. Cases were notifications of laboratory-confirmed influenza, and controls were individuals who were test negative for COVID-19. Cases and controls were matched on age, postcode and specimen collection date. VE against hospitalisation was investigated by matching hospitalised cases to controls. Conditional logistic regression models were adjusted for sex.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2022, Queensland experienced an early influenza season onset (April-May) and high case numbers (n = 45,311), compared to the previous 5 years (annual average: 29,364) and 2020-2021 (2020:6047; 2021:301) during the COVID-19 pandemic. Adjusted VE (VE<sub>ad</sub>j) against laboratory-confirmed influenza was 39% (95% confidence interval [CI]: 37-41), highest for children aged 30 months to &lt; 5 years (61%, 95% CI: 49-70) and lowest for adults aged ≥ 65 years (24%, 95% CI: 17-30). VE<sub>adj</sub> against influenza-associated hospitalisation was 54% (95% CI: 48-59). Among children &lt; 9 years of age, VE<sub>adj</sub> against laboratory-confirmed influenza (55%, 95% CI: 49-61) and hospitalisation (67%, 95% CI: 39-82) was higher in those who received a complete dose schedule.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In Queensland, the 2022 influenza season started earlier than the previous 5 years. VE against influenza notifications varied across age groups. VE estimates against influenza-associated hospitalisation were higher than those against laboratory-confirmed influenza.</AbstractText><CopyrightInformation>© 2024 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Ashish C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-5049-8351</Identifier><AffiliationInfo><Affiliation>Queensland Public Health and Scientific Services, Queensland Health, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangarajah</LastName><ForeName>Dharshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health and Aged Care, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Ross</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Queensland Public Health and Scientific Services, Queensland Health, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ware</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Griffith Biostatistics Unit, Griffith University, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Stephen B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-2709-193X</Identifier><AffiliationInfo><Affiliation>Queensland Public Health and Scientific Services, Queensland Health, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Immunisation Research and Surveillance, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Australian National University Master of Philosophy (Applied Epidemiology) Scholarship</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011793" MajorTopicYN="N" Type="Geographic">Queensland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087507" MajorTopicYN="Y">Vaccine Efficacy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Australia</Keyword><Keyword MajorTopicYN="N">Queensland</Keyword><Keyword MajorTopicYN="N">flu</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">influenza vaccine</Keyword><Keyword MajorTopicYN="N">vaccine effectiveness</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>8</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39320009</ArticleId><ArticleId IdType="pmc">PMC11423337</ArticleId><ArticleId IdType="doi">10.1111/irv.70007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tyrrell C. S., Allen J. L. Y., and Gkrania‐Klotsas E., “Influenza: Epidemiology and Hospital Management,” Medicine (Abingdon). 49, no. 12 (2021): 797–804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8624711</ArticleId><ArticleId IdType="pubmed">34849086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay L. C., Buchan S. A., Stirling R. G., et al., “The Impact of Repeated Vaccination on Influenza Vaccine Effectiveness: A Systematic Review and Meta‐Analysis,” BMC Medicine 17, no. 1 (2019): 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327561</ArticleId><ArticleId IdType="pubmed">30626399</ArticleId></ArticleIdList></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, Australian National Notifiable Diseases and Case Definitions (Canberra: Australian Government Department of Health and Aged Care, 2021.  (cited 2022 Jun 06). Available from:), https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna‐casedefinitions.htm.</Citation></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, National Immunisation Program Schedule (Canberra: Australian Government Department of Health and Aged Care, 2022.  (cited 2022 Jun 07). Available from:), https://www.health.gov.au/health‐topics/immunisation/when‐to‐get‐vaccinated/national‐immunisation‐program‐schedule#flu‐influenza‐vaccines.</Citation></Reference><Reference><Citation>
National Centre for Immunisation Research and Surveillance
, Significant Events in Influenza Vaccination Practice in Australia[Internet] (NSW: National Centre for Immunisation Research and Surveillance, 2022.  [cited 2024 Jan 14]. Available from:), https://ncirs.org.au/sites/default/files/2022‐11/Influenza‐history‐November%202022.pdf.</Citation></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, National Notifiable Disease Surveillance System: National Communicable Disease Surveillance Dashboard [Internet] (Canberra: Australian Government Department of Health and Aged Care, 2022.  [cited 2023 Aug 11]. Available from:), https://nindss.health.gov.au/pbi‐dashboard/.</Citation></Reference><Reference><Citation>
Queensland Government
, Free Flu Jab Extended to Protect More Queenslanders (Brisbane: Queensland Government, 2022.  (cited 2022 Jul 10). Available from:), https://statements.qld.gov.au/statements/95572.</Citation></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, AIVC Recommendations for the Composition of Influenza Vaccine for Australia in 2022 (Canberra: Australian Government Department of Health and Aged Care, 2021.  (cited 2022 Jun 07). Available from:), https://www.tga.gov.au/aivc‐recommendations‐composition‐influenza‐vaccine‐australia‐2022.</Citation></Reference><Reference><Citation>Thangarajah D., Malo J. A., Field E., Andrews R., Ware R. S., and Lambert S. B., “Effectiveness of Quadrivalent Influenza Vaccination in the First Year of a Funded Childhood Program in Queensland, Australia, 2018,” Vaccine 39, no. 4 (2021): 729–737.</Citation><ArticleIdList><ArticleId IdType="pubmed">33358414</ArticleId></ArticleIdList></Reference><Reference><Citation>
Queensland Health
, Guidelines for Laboratories (Brisbane: Queensland Health, 2022.  [cited 2022 Jul 25]. Available from:), https://www.health.qld.gov.au/__data/assets/pdf_file/0034/429694/notif‐criteria‐guide.pdf.</Citation></Reference><Reference><Citation>
Australian Bureau of Statistics
, National, State and Territory Population [Internet] (Canberra: Australian Bureau of Statistics, 2022.  [cited 2022 Oct 10]. Available from:), https://www.abs.gov.au/statistics/people/population/national‐state‐and‐territory‐population/latest‐release#data‐download.</Citation></Reference><Reference><Citation>
World Health Organization
, Evaluation of Influenza Vaccine Effectiveness [Internet] (Geneva: World Health Organization, 2017.  [cited 2022 Jun 06]. Available from:), https://apps.who.int/iris/bitstream/handle/10665/255203/9789241512121‐eng.pdf.</Citation></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, Influenza (Flu) [Internet] (Canberra ACT: Australian Government Department of Health and Aged Care, 2022.  [updated 2022 April 21; cited 2022 Jun 17]. Available from:), https://immunisationhandbook.health.gov.au/contents/vaccine‐preventable‐diseases/influenza‐flu#accordion‐para‐8466‐186703.</Citation></Reference><Reference><Citation>Cheng A. C., Dwyer D. E., Holmes M., et al., “Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Sentinel Australian Hospitals in 2013: The Influenza Complications Alert Network,” Communicable Diseases Intelligence Quarterly Report 38, no. 2 (2014): E143–E149.</Citation><ArticleIdList><ArticleId IdType="pubmed">25222208</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A. C., Kotsimbos T., and Kelly P. M., “Influenza Vaccine Effectiveness Against Hospitalisation With Influenza in Adults in Australia in 2014,” Vaccine 33, no. 51 (2015): 7352–7356.</Citation><ArticleIdList><ArticleId IdType="pubmed">26529066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielding J. E., Levy A., Chilver M. B., et al., “Effectiveness of Seasonal Influenza Vaccine in Australia, 2015: An Epidemiological, Antigenic and Phylogenetic Assessment,” Vaccine 34, no. 41 (2016): 4905–4912.</Citation><ArticleIdList><ArticleId IdType="pubmed">27577556</ArticleId></ArticleIdList></Reference><Reference><Citation>Regan A. K., Gibbs R., Bloomfield L., and Effler P. V., “Estimating Influenza Vaccine Effectiveness Using Data Routinely Available in Electronic Primary Care Records,” Vaccine 37, no. 5 (2019): 755–762, 10.1016/j.vaccine.2018.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.12.006</ArticleId><ArticleId IdType="pubmed">30600119</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman D. A., Cheng A. C., Macartney K. K., et al., “Influenza Hospitalizations in Australian Children 2010−2019: The Impact of Medical Comorbidities on Outcomes, Vaccine Coverage, and Effectiveness,” Influenza and Other Respiratory Viruses 16, no. 2 (2022): 316–327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818821</ArticleId><ArticleId IdType="pubmed">34787369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan S. G., Arriola C. S., Bocacao J., et al., “Heterogeneity in Influenza Seasonality and Vaccine Effectiveness in Australia, Chile, New Zealand and South Africa: Early Estimates of the 2019 Influenza Season,” Euro Surveillance 24, no. 45 (2019), 1900645, 10.2807/1560-7917.Es.2019.24.45.1900645.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.Es.2019.24.45.1900645</ArticleId><ArticleId IdType="pmc">PMC6852316</ArticleId><ArticleId IdType="pubmed">31718744</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyth C. C., Cheng A. C., Crawford N. W., et al., “The Impact of new Universal Child Influenza Programs in Australia: Vaccine Coverage, Effectiveness and Disease Epidemiology in Hospitalised Children in 2018,” Vaccine 38, no. 13 (2020): 2779–2787.</Citation><ArticleIdList><ArticleId IdType="pubmed">32107062</ArticleId></ArticleIdList></Reference><Reference><Citation>Price A. M., Flannery B., Talbot H. K., et al., “Influenza Vaccine Effectiveness Against Influenza A(H3N2)‐Related Illness in the United States During the 2021‐2022 Influenza Season,” Clinical Infectious Diseases 76, no. 8 (2023): 1358–1363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10893961</ArticleId><ArticleId IdType="pubmed">36504336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissling E., Pozo F., Martínez‐Baz I., et al., “Influenza Vaccine Effectiveness Against Influenza a Subtypes in Europe: Results From the 2021‐2022 I‐MOVE Primary Care Multicentre Study,” Influenza and Other Respiratory Viruses 17, no. 1 (2023): e13069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9835407</ArticleId><ArticleId IdType="pubmed">36702797</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M. W., Weber Z. A., DeSilva M. B., et al., “Vaccine Effectiveness Against Influenza‐Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021‐2022 Season, VISION Network,” The Journal of Infectious Diseases 228, no. 2 (2023): 185–195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11306092</ArticleId><ArticleId IdType="pubmed">36683410</ArticleId></ArticleIdList></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, Australian Influenza Surveillance Report (Canberra: Australian Government Department of Health and Aged Care, 2022.  (cited 2023 Aug 14). Available from:), https://www.health.gov.au/sites/default/files/documents/2022/10/aisr‐fortnightly‐report‐no‐14‐26‐september‐to‐9‐october‐2022.pdf.</Citation></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, Mandatory Reporting of National Immunisation Program Vaccines to the Australian Immunisation Register Began on 1 July 2021 (Canberra: Australian Government Department of Health and Aged Care, 2021.  (cited 2023 Nov 06). Available from:), https://www.health.gov.au/news/mandatory‐reporting‐of‐national‐immunisation‐program‐vaccines‐to‐the‐australian‐immunisation‐register‐began‐on‐1‐july‐2021.</Citation></Reference><Reference><Citation>
Australian Government Department of Health and Aged Care
, Australian Influenza Surveillance Report – 2023 End of Season Summary (Canberra: Australian Government Department of Health and Aged Care, 2023.  (cited 2024 Jul 25). Available from:), https://www.health.gov.au/sites/default/files/2023‐12/aisr‐2023‐national‐influenza‐season‐summary.pdf.</Citation></Reference><Reference><Citation>
National Centre for Immunisation Research and Surveillance
, Significant Events in Influenza Vaccination Practice in Australia[Internet] (NSW: National Centre for Immunisation Research and Surveillance, 2022.  [cited 2024 Jul 19]. Available from:), https://ncirs.org.au/sites/default/files/2024‐01/NCIRS_Annual%20immunisation%20coverage%20report%202022_Summary.pdf.</Citation></Reference><Reference><Citation>Doll M. K., Pettigrew S. M., Ma J., and Verma A., “Effects of Confounding Bias in Coronavirus Disease 2019 (COVID‐19) and Influenza Vaccine Effectiveness Test‐Negative Designs due to Correlated Influenza and COVID‐19 Vaccination Behaviors,” Clinical Infectious Diseases 75, no. 1 (2022): e564–e571, 10.1093/cid/ciac234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac234</ArticleId><ArticleId IdType="pmc">PMC9129127</ArticleId><ArticleId IdType="pubmed">35325923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M. W., Patel M. M., Lewis N. M., et al., “Vaccine Effectiveness Against Influenza A(H3N2)‐associated Hospitalized Illness: United States, 2022,” Clinical Infectious Diseases 76, no. 6 (2023): 1030–1037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10226741</ArticleId><ArticleId IdType="pubmed">36327388</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuchter R. K., Jackson N. J., Mafi J. N., and Sarkisian C. A., “Association Between Covid‐19 Vaccination and Influenza Vaccination Rates,” New England Journal of Medicine 386, no. 26 (2022): 2531–2532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258773</ArticleId><ArticleId IdType="pubmed">35704429</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitelhuber T., Ngeh S., Bloomfield L., Chandaria B., and Effler P., “Using Data Linkage to Monitor COVID‐19 Vaccination: Development of a Vaccination Linked Data Repository,” Int J Popul Data Sci. 5, no. 4 (2020): 1730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10464866</ArticleId><ArticleId IdType="pubmed">37649990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>